Early last week, Infosys won a large deal with the investment management firm Vanguard for digital transformation.
Indian IT firm Infosys and German firm LANXESS entered into a long term partnership for digital and workplace transformation. LANXESS manufactures chemical intermediates, additives, specialty chemicals in Germany.
As a part of the tie-up, India’s second-largest IT services firm will support LANXESS in its IT infrastructure digitisation strategy and enable its global workforce spread across 33 countries using a secure and fully managed modern workplace, according to a company statement.
Infosys will set up end-user centric modern workplace, which supports multi-lingual artificial intelligence-powered service desk operating from Europe and India for the LANXESS’s workforce, the statement added.
Germany is a very strategic market for Infosys and is an important part of the localisation strategy in Europe, said Jasmeet Singh, Executive Vice President and Global Head of Manufacturing at Infosys.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
“In today’s world, digital workplace as a service is becoming increasingly relevant for all our clients’ transformation journeys and we are glad to be partnering with LANXESS to enable their transition to a modern digital workplace,” the statement added.
This is in the long line of digital and workplace transformation deals the IT major has signed in the last two weeks.
On July 10, Infosys and US-based Old National Bank entered into a partnership for a digital transformation deal. Early last week, Infosys won a multi-year large deal with the investment management firm Vanguard, It is valued at $1.5 billion and could go up to $2 billion in the next 10 years, The Times of India reported.
Vendor consolidation, where clients are looking for a single vendor for IT, and increasing investment in digital are driving the demand for the company on the back of COVID-19, according to Salil Parekh, CEO, Infosys, said at a recent press briefing.For the quarter-ending June, the company registered an impressive 1.5 percent growth in constant currency driven by digital. Of the $1.7 billion deal, the company signed in Q1, majority of which were digital transformation deals.